Statistics indicate that one in eight women will develop breast cancer sometime in her lifetime. The stage at which breast cancer is detected influences a woman’s chance of survival. If detected early, the five-year survival rate is 97 percent.

MetroHealth is committed to the fight against breast cancer. In offering new 3-D breast tomosynthesis digital mammography, our Beachwood Health Center provides the latest in imaging quality.

This means that women who undergo routine mammograms at MetroHealth Beachwood Health Center now have the latest screening and diagnostic technology available to them. MetroHealth Beachwood is one of the first women’s centers in the United States to offer 3-D breast tomosynthesis for breast cancer screening.

The technology offers exceptionally sharp breast images, an advanced ergonomic design providing more patient comfort, and a groundbreaking 3-D tomosynthesis platform designed to deliver superior screening and diagnostic performance.

"This new 3-D breast imaging will be particularly useful in women with dense breast tissue," says Barbara Rhoads, MD, OB/GYN, at MetroHealth Beachwood and Lee-Harvard health centers.

Breast tomosynthesis is a revolutionary technology that gives radiologists the ability to identify and characterize individual breast structures without the confusion of overlapping tissue. 

During a tomosynthesis exam, multiple, low-dose images of the breast are acquired at different angles.  These images are then used to produce a series of one-millimeter thick slices that can be viewed as a 3-D reconstruction of the breast.

There are more than 8,000 breast cancer screening sites in the United States. Nearly 5,000 have at least one digital mammography system. Less than 100 have installed this newest generation of digital mammography equipment.

By offering women the latest technology in mammography, MetroHealth Beachwood hopes to increase the number of area women who will be routinely screened.

To schedule a mammogram with a physician’s order, please call 216-957-9959.